Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 1,041–1,048 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
BioVie Inc. BIV201 Ascites Phase 2b Trial Planned Intravenous Gastroenterology
BioVie Inc. NE3107 Alzheimer’s disease Phase 3 Data Released Oral Neurology
BioVie Inc. Bezisterim (NE3107) - (Biomarker Trial) Alzheimer's disease Phase 2 Data Released Oral Neurology
BioVie Inc. NE3107 Parkinson's disease Phase 2a Data Released Oral Neurology
BioVie Inc. Bezisterim - (SUNRISE-PD) Parkinson's Disease Phase 2 Ongoing Oral Neurology
BioVie Inc. Bezisterim (NE3107) - (ADDRESS-LC) Long COVID Phase 2 Ongoing oral COVID-19
BioVie Inc. Bezisterim Neurological symptoms that are associated with long COVID Phase 2 IND Clearance Oral Neurology
BioXcel Therapeutics Inc. Dexmedetomidine (BXCL501) - (TRANQUILITY II) Agitation associated with Alzheimer’s Disease Phase 3 Ongoing Sublingual Psychiatric
1…129130131132133…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.